These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12740921)

  • 21. Familial risks for nonmedullary thyroid cancer.
    Hemminki K; Eng C; Chen B
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5747-53. PubMed ID: 16030170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden.
    Hemminki K; Li X
    Gut; 2003 Apr; 52(4):592-6. PubMed ID: 12631675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stage at diagnosis of ovarian cancer in the United States, 1992-1997.
    Goodman MT; Correa CN; Tung KH; Roffers SD; Cheng Wu X; Young JL; Wilkens LR; Carney ME; Howe HL
    Cancer; 2003 May; 97(10 Suppl):2648-59. PubMed ID: 12733130
    [No Abstract]   [Full Text] [Related]  

  • 24. Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?
    Goshen R; Chu W; Elit L; Pal T; Hakimi J; Ackerman I; Fyles A; Mitchell M; Narod SA
    Gynecol Oncol; 2000 Dec; 79(3):477-81. PubMed ID: 11104623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial risk for esophageal cancer: an updated epidemiologic study from Sweden.
    Ji J; Hemminki K
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):840-5. PubMed ID: 16678496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
    Pal T; Permuth-Wey J; Betts JA; Krischer JP; Fiorica J; Arango H; LaPolla J; Hoffman M; Martino MA; Wakeley K; Wilbanks G; Nicosia S; Cantor A; Sutphen R
    Cancer; 2005 Dec; 104(12):2807-16. PubMed ID: 16284991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The risk of contralateral breast cancer in daughters of women with and without breast cancer.
    Narod SA; Kharazmi E; Fallah M; Sundquist K; Hemminki K
    Clin Genet; 2016 Mar; 89(3):332-5. PubMed ID: 25920602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial breast cancer: scope for more susceptibility genes?
    Hemminki K; Granström C
    Breast Cancer Res Treat; 2003 Nov; 82(1):17-22. PubMed ID: 14672399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression profiles in three histologic types, clear-cell, endometrioid and serous ovarian carcinomas.
    Pamuła-Piłat J; Rubel T; Rzepecka IK; Olbryt M; Herok R; Dansonka-Mieszkowska A; Grzybowska E; Kupryjańczyk J
    J Biol Regul Homeost Agents; 2014; 28(4):659-74. PubMed ID: 25620176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inherited predisposition to early onset lung cancer according to histological type.
    Li X; Hemminki K
    Int J Cancer; 2004 Nov; 112(3):451-7. PubMed ID: 15382071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway.
    Hemminki K; Tretli S; Sundquist J; Johannesen TB; Granström C
    Lancet Oncol; 2009 May; 10(5):481-8. PubMed ID: 19356978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial and second gastric carcinomas: a nationwide epidemiologic study from Sweden.
    Hemminki K; Jiang Y
    Cancer; 2002 Feb; 94(4):1157-65. PubMed ID: 11920487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mutation of breast cancer susceptibility gene in ovarian cancer and its clinical significance].
    Shi H; You Z; Guo Y
    Zhonghua Fu Chan Ke Za Zhi; 1998 Nov; 33(11):676-8. PubMed ID: 10806719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial breast and ovarian cancer: a Swedish population-based register study.
    Anderson H; Bladström A; Olsson H; Möller TR
    Am J Epidemiol; 2000 Dec; 152(12):1154-63. PubMed ID: 11130621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial risk of cancer: data for clinical counseling and cancer genetics.
    Hemminki K; Li X; Czene K
    Int J Cancer; 2004 Jan; 108(1):109-14. PubMed ID: 14618624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRCA1 and BRCA2 mutations in central and southern Italian patients.
    Ottini L; D'Amico C; Noviello C; Lauro S; Lalle M; Fornarini G; Colantuoni OA; Pizzi C; Cortesi E; Carlini S; Guadagni F; Bianco AR; Frati L; Contegiacomo A; Mariani-Costantini R
    Breast Cancer Res; 2000; 2(4):307-10. PubMed ID: 11056688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study.
    Olsen JH; Seersholm N; Boice JD; Krüger Kjaer S; Fraumeni JF
    Br J Cancer; 1999 Feb; 79(3-4):673-9. PubMed ID: 10027348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of histological subtype in developing both ovarian and endometrial cancer: A longstanding nationwide incidence study.
    van Niekerk CC; van Dijck JAAM; Verbeek ALM
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():17-22. PubMed ID: 29227847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer among first-degree relatives of probands with invasive and borderline ovarian cancer.
    Rader JS; Neuman RJ; Brady J; Babb S; Temple S; Kost E; Mutch DG; Herzog TJ
    Obstet Gynecol; 1998 Oct; 92(4 Pt 1):589-95. PubMed ID: 9764634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary ovarian cancer syndromes in three Pakistani families.
    Aziz AB; Sabih M; Malik IA
    J Pak Med Assoc; 1996 Sep; 46(9):201-3. PubMed ID: 8936986
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.